Sen. Chuck Grassley (R-Iowa) said the FTC commissioners should work together to probe the entities that manage prescription drug coverage for insurers after a proposed study failed to get enough support last month.
Grassley, ranking member of the Senate Judiciary Committee, wrote in a letter dated Wednesday to Federal Trade Commission Chair Lina Khan that there is “widespread bipartisan support for examining” pharmacy benefit managers and “whether they are causing Americans to pay higher prices for prescription drugs.”
The senator urged Khan to “find consensus” on a probe into a component of the health-care industry that has drugmakers, pharmacies, and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.